Literature DB >> 31165439

Marine anticancer drugs and their relevant targets: a treasure from the ocean.

Manisha Nigam1, Hafiz Ansar Rasul Suleria2,3,4, Mohammad Hosein Farzaei5, Abhay Prakash Mishra6.   

Abstract

Marine organisms comprising animals and plants are wealthiest sources of bioactive compounds possessing various pharmacological properties specifically: free radical scavenging, antitumor, antimicrobial, analgesic, neuroprotective and immunomodulatory. Marine drugs provide an alternative source to meet the demand of effective, safe and low-cost drugs that are rising with the continuously growing world population. Cancer is one of the leading reasons of mortality in western nations in contrast to communicable diseases of developing nations. In spite of outstanding developments in cancer therapy in past three decades, there is still an insistent necessity for innovative drugs in the area of cancer biology, especially in the unexplored area of marine anticancer compounds. However, recent technological innovations in structure revelation, synthetic creation of new compounds and biological assays have made possible the isolation and clinical assessment of innumerable unique anticancer compounds from marine environment. This review provides an insight into the anticancer research so far conducted in the area of the marine natural products/synthetic derivatives, their possible molecular targets and the current challenges in the drug development. Graphical abstract.

Entities:  

Keywords:  Antiproliferation; Apoptosis; Autophagy; Cell death; Cytotoxic; Marine bioactive compounds

Mesh:

Substances:

Year:  2019        PMID: 31165439      PMCID: PMC6593002          DOI: 10.1007/s40199-019-00273-4

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


  153 in total

Review 1.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

Authors:  G Pearson; F Robinson; T Beers Gibson; B E Xu; M Karandikar; K Berman; M H Cobb
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

Review 2.  The discovery and development of marine compounds with pharmaceutical potential.

Authors:  M H Munro; J W Blunt; E J Dumdei; S J Hickford; R E Lill; S Li; C N Battershill; A R Duckworth
Journal:  J Biotechnol       Date:  1999-04-30       Impact factor: 3.307

Review 3.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 4.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

5.  Suppression of tumor growth through disruption of hypoxia-inducible transcription.

Authors:  A L Kung; S Wang; J M Klco; W G Kaelin; D M Livingston
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

6.  Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

Authors:  H Luesch; R E Moore; V J Paul; S L Mooberry; T H Corbett
Journal:  J Nat Prod       Date:  2001-07       Impact factor: 4.050

7.  Evaluation of the antioxidant activity of environmental plants: activity of the leaf extracts from seashore plants.

Authors:  T Masuda; S Yonemori; Y Oyama; Y Takeda; T Tanaka; T Andoh; A Shinohara; M Nakata
Journal:  J Agric Food Chem       Date:  1999-04       Impact factor: 5.279

Review 8.  Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

Authors:  M Höckel; P Vaupel
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

9.  Cytotoxic and tubulin-interactive hemiasterlins from Auletta sp. and Siphonochalina spp. sponges.

Authors:  W R Gamble; N A Durso; R W Fuller; C K Westergaard; T R Johnson; D L Sackett; E Hamel; J H Cardellina; M R Boyd
Journal:  Bioorg Med Chem       Date:  1999-08       Impact factor: 3.641

10.  Mode of action of thiocoraline, a natural marine compound with anti-tumour activity.

Authors:  E Erba; D Bergamaschi; S Ronzoni; M Faretta; S Taverna; M Bonfanti; C V Catapano; G Faircloth; J Jimeno; M D'Incalci
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

View more
  4 in total

1.  Inhibition of A549 Lung Cancer Cell Migration and Invasion by Ent-Caprolactin C via the Suppression of Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition.

Authors:  So Young Kim; Myoung-Sook Shin; Geum Jin Kim; Hyukbean Kwon; Myong Jin Lee; Ah-Reum Han; Joo-Won Nam; Chan-Hun Jung; Ki Sung Kang; Hyukjae Choi
Journal:  Mar Drugs       Date:  2021-08-19       Impact factor: 5.118

2.  Cancer Cell Inhibiting Sea Cucumber (Holothuria leucospilota) Protein as a Novel Anti-Cancer Drug.

Authors:  Ruizhen Ru; Yanzheng Guo; Juanxuan Mao; Zonghe Yu; Wen Huang; Xudong Cao; Huijian Hu; Minjie Meng; Lihong Yuan
Journal:  Nutrients       Date:  2022-02-13       Impact factor: 5.717

Review 3.  The Chemotherapeutic Potentials of Compounds Isolated from the Plant, Marine, Fungus, and Microorganism: Their Mechanism of Action and Prospects.

Authors:  Ashok K Shakya; Rajashri R Naik
Journal:  J Trop Med       Date:  2022-10-10

4.  Detection of a pederin-like compound using a dilution-to-extinction-based platform for the isolation of marine bacteria in drug discovery strategies.

Authors:  Xulio Benítez; Elena G Gonzalez; Jesus García; Paz Zúñiga; Fernando de la Calle; Carmen Cuevas
Journal:  Microb Biotechnol       Date:  2020-10-23       Impact factor: 5.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.